[Oxaliplatin-induced peripheral neuropathy: how to create a barrier?]
暂无分享,去创建一个
[1] X. Navarro,et al. Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies , 2019, Experimental Neurology.
[2] B. Ehrlich,et al. Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings. , 2019, Critical reviews in oncology/hematology.
[3] F. Bosco,et al. The Role of Endothelial Dysfunction in Peripheral Blood Nerve Barrier: Molecular Mechanisms and Pathophysiological Implications , 2019, International journal of molecular sciences.
[4] L. Colvin. Chemotherapy-induced peripheral neuropathy: where are we now? , 2019, Pain.
[5] T. Jensen,et al. Functional and Structural Changes of the Blood-Nerve-Barrier in Diabetic Neuropathy , 2019, Front. Neurosci..
[6] K. Taguchi,et al. Oxaliplatin-induced changes in expression of transient receptor potential channels in the dorsal root ganglion as a neuropathic mechanism for cold hypersensitivity , 2017, Neuropeptides.
[7] Preti Jain,et al. The Human Blood-Nerve Barrier Transcriptome , 2017, Scientific Reports.
[8] G. Ciarimboli,et al. Role of transporters in the distribution of platinum-based drugs , 2015, Front. Pharmacol..
[9] Gillian L. Currie,et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis , 2014, PAIN®.
[10] A. Shields,et al. Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2 , 2013, Proceedings of the National Academy of Sciences.
[11] C. Shapiro,et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. , 2013, JAMA.
[12] A. Windebank,et al. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. , 2012, Neuro-oncology.
[13] T. Hambley,et al. Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs , 2000, British Journal of Cancer.